IMTX
Price
$5.77Alerts
Change
-$0.18 (-3.03%)
Updated
Nov 20 closing price
Capitalization
968.15M
122 days until earnings call
Intraday BUY SELL Signals
ROIV
Price
$38.66Alerts
Change
-$0.31 (-0.80%)
Updated
Nov 20 closing price
Capitalization
28.08B
85 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMTX vs ROIV

IMTX vs ROIV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMTX vs. ROIV commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Hold and ROIV is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IMTX with price predictions
Nov 20, 2026

IMTX's Indicator enters downward trend

The Aroon Indicator for IMTX entered a downward trend on November 20, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 246 similar instances where the Aroon Indicator formed such a pattern. In 213 of the 246 cases the stock moved lower. This puts the odds of a downward move at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IMTX as a result. In 77 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for IMTX turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 40 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMTX advanced for three days, in 221 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

IMTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.423) is normal, around the industry mean (3.596). P/E Ratio (-4.000) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (23.202) is also within normal values, averaging (443.347).

The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. IMTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ROIV with price predictions
Nov 20, 2026

ROIV in upward trend: 10-day moving average crossed above 50-day moving average on November 03, 2026

The 10-day moving average for ROIV crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ROIV moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +0.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where ROIV advanced for three days, in 232 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

The Aroon Indicator entered an Uptrend today. In 187 of 239 cases where ROIV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

Bearish Trend Analysis

The 10-day RSI Indicator for ROIV moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 30 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 57 cases where ROIV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.

The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ROIV as a result. In 73 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.

The Moving Average Convergence Divergence Histogram (MACD) for ROIV turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In 40 of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ROIV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

ROIV broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.637) is normal, around the industry mean (3.596). ROIV has a moderately low P/E Ratio (-108.000) as compared to the industry average of (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. ROIV's P/S Ratio (3333.333) is slightly higher than the industry average of (443.347).

The Tickeron Profit vs. Risk Rating rating for this company is 6 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. ROIV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 67 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
IMTX vs ROIV: Fundamental Ratings
IMTX
ROIV
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
3
Undervalued
PROFIT vs RISK RATING
1..100
1006
SMR RATING
1..100
9892
PRICE GROWTH RATING
1..100
8237
P/E GROWTH RATING
1..100
1667
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ROIV's Valuation (3) in the null industry is in the same range as IMTX (32). This means that ROIV’s stock grew similarly to IMTX’s over the last 12 months.

ROIV's Profit vs Risk Rating (6) in the null industry is significantly better than the same rating for IMTX (100). This means that ROIV’s stock grew significantly faster than IMTX’s over the last 12 months.

ROIV's SMR Rating (92) in the null industry is in the same range as IMTX (98). This means that ROIV’s stock grew similarly to IMTX’s over the last 12 months.

ROIV's Price Growth Rating (37) in the null industry is somewhat better than the same rating for IMTX (82). This means that ROIV’s stock grew somewhat faster than IMTX’s over the last 12 months.

IMTX's P/E Growth Rating (16) in the null industry is somewhat better than the same rating for ROIV (67). This means that IMTX’s stock grew somewhat faster than ROIV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXROIV
RSI
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
74%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 14 days ago
76%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 7 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
78%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (IMTX: $5.77 vs. ROIV: $38.65)
Brand notoriety: IMTX and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 64% vs. ROIV: 49%
Market capitalization -- IMTX: $968.15M vs. ROIV: $28.08B
IMTX [@Biotechnology] is valued at $968.15M. ROIV’s [@Biotechnology] market capitalization is $28.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 2 FA rating(s) are green while ROIV’s FA Score has 2 green FA rating(s).

  • IMTX’s FA Score: 2 green, 3 red.
  • ROIV’s FA Score: 2 green, 3 red.
According to our system of comparison, ROIV is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • IMTX’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than ROIV.

Price Growth

IMTX (@Biotechnology) experienced а -9.70% price change this week, while ROIV (@Biotechnology) price change was -2.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.58%. For the same industry, the average monthly price growth was -18.26%, and the average quarterly price growth was -28.15%.

Reported Earning Dates

IMTX is expected to report earnings on Mar 24, 2027.

ROIV is expected to report earnings on Feb 15, 2027.

Industries' Descriptions

@Biotechnology (-11.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with SLDB. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-3.03%
SLDB - IMTX
53%
Loosely correlated
-2.95%
BCYC - IMTX
48%
Loosely correlated
-4.92%
VIR - IMTX
48%
Loosely correlated
-5.41%
TSHA - IMTX
48%
Loosely correlated
-1.33%
SANA - IMTX
47%
Loosely correlated
-8.62%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCIC5.220.09
+1.75%
BCP Investment Corporation
SEPN38.61-0.59
-1.51%
Septerna Inc
SUZ9.10-0.17
-1.83%
Suzano SA
MNPR69.00-1.29
-1.84%
Monopar Therapeutics Inc
SGLY0.39-0.02
-5.61%
Singularity Future Technology Ltd